These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Teicoplanin therapy in children: a review.
    Author: Bassetti D, Cruciani M.
    Journal: Scand J Infect Dis Suppl; 1990; 72():35-7. PubMed ID: 2151065.
    Abstract:
    Teicoplanin has been investigated mainly in adults and to a lesser extent in children. Pharmacological studies in children aged 2-12 years showed that a daily dose of 3-6 mg/kg of teicoplanin was insufficient to maintain microbiologically effective trough serum levels, while a regimen of 10 mg/kg/day was sufficient to obtain effective serum concentrations. Teicoplanin has been administered, alone or in combination therapy, to neutropenic or non-neutropenic paediatric patients. Combinations of teicoplanin (10 mg/kg/day) plus beta-lactams or aminoglycosides have been found effective in the treatment of febrile episodes in neutropenic (less than 500 pmn/microliters) children. Teicoplanin, 3-10 mg/kg i.v., has been administered as the sole antibiotic agent as a daily dose to more than 100 children and newborns with documented or suspected Gram-positive infections. Overall, teicoplanin was found to be a very effective and well tolerated treatment for Gram-positive infections in pediatric patients. Further trials are required to confirm these observations.
    [Abstract] [Full Text] [Related] [New Search]